tiprankstipranks
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm Data Validate TLR8-Targeted Oligonucleotide Cancer Strategy
Company AnnouncementsNoxopharm Data Validate TLR8-Targeted Oligonucleotide Cancer Strategy
1h ago
NOX
Noxopharm advances Sofra platform as SOF-SKN nears FDA milestone
PremiumCompany Announcements
Noxopharm advances Sofra platform as SOF-SKN nears FDA milestone
13d ago
NOX
Noxopharm moves SOF-SKN toward U.S. FDA pathway to boost autoimmune portfolio
PremiumCompany Announcements
Noxopharm moves SOF-SKN toward U.S. FDA pathway to boost autoimmune portfolio
28d ago
NOX
Noxopharm Sofra Platform Backed in $1m Grant for Childbirth Injury Treatment
PremiumCompany Announcements
Noxopharm Sofra Platform Backed in $1m Grant for Childbirth Injury Treatment
1M ago
NOX
Noxopharm unveils human-like TLR8 model to accelerate cancer immunotherapy program
PremiumCompany Announcements
Noxopharm unveils human-like TLR8 model to accelerate cancer immunotherapy program
1M ago
NOX
Noxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
PremiumCompany AnnouncementsNoxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
2M ago
NOX
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
Premium
Company Announcements
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
2M ago
NOX
Noxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
Premium
Company Announcements
Noxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
2M ago
NOX
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
PremiumCompany Announcements
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
3M ago
NOX
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
PremiumCompany Announcements
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
3M ago
NOX
Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
PremiumCompany Announcements
Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
3M ago
NOX
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
PremiumCompany Announcements
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
3M ago
NOX
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
PremiumCompany AnnouncementsNoxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
3M ago
NOX
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
Premium
Company Announcements
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
3M ago
NOX
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
Premium
Company Announcements
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
4M ago
NOX
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
PremiumCompany Announcements
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
4M ago
NOX
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
PremiumCompany Announcements
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
5M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
5M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
5M ago
NOX
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
PremiumCompany AnnouncementsNoxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
5M ago
NOX
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
Premium
Company Announcements
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
5M ago
NOX
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
Premium
Company Announcements
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
6M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >